Related Experiment Video
Updated: May 15, 2026
04:53
A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
Published on: September 20, 2019
Credentialing for participation in clinical trials
David S Followill1, Marcia Urie, James M Galvin
1Radiological Physics Center, Department of Radiation Physics, University of Texas MD Anderson Cancer Center Houston, TX, USA.
Frontiers in Oncology
|December 29, 2012
Summary
The National Cancer Institute (NCI) is transforming clinical trials for faster patient care improvements. This involves streamlining credentialing processes for radiation therapy trials and enhancing international collaboration.
Area of Science:
- Oncology
- Clinical Trials Methodology
- Radiation Therapy
Background:
- National Cancer Institute (NCI) clinical cooperative groups have a 50-year history of developing clinical trials.
- These groups are crucial for evidence-based improvements in cancer patient care.
- Current processes are being transformed for more rapid trial initiation, conduct, and publication.
Purpose of the Study:
- To review current processes in radiation therapy clinical trials.
- To emphasize the importance of effective credentialing for trial quality.
- To propose strategies for streamlining and harmonizing credentialing during NCI transformation.
Main Methods:
- Review of existing processes in NCI-supported radiation therapy trials.
- Analysis of credentialing strategies and their impact on trial outcomes.
- Identification of opportunities for harmonization and efficiency improvements.
Main Results:
- Current credentialing processes can be complex and vary across institutions.
- Effective credentialing is vital for ensuring the reliability and validity of clinical trial data.
- Streamlining efforts can enhance institutional participation and international collaboration.
Conclusions:
- Harmonizing credentialing tools and processes is essential for efficient NCI clinical trial conduct.
- Adapting credentialing is key to supporting the NCI's transformation goals.
- Improved processes will accelerate the delivery of evidence-based cancer care.
Related Concept Videos
01:16Clinical Trials
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
01:11Clinical Trials: Overview
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
01:28Preclinical Development: Overview
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
01:11Blinding
Blinding is a commonly used method of not telling participants which treatment a subject is receiving. Blinding is a critical part of a randomized control trial or RCT. It reduces the bias that affects the results. In an RCT, blinding is used in the form of a placebo. A placebo effect occurs when untreated subjects falsely believe they have received the treatment and report improved symptoms. A placebo or a dummy treatment is administered to subjects to negate the bias caused by such an effect.
01:15Bioavailability Study Design: Healthy Subjects Versus Patients
Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...